Corrigendum: Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects

In the original article, there was a mistake in Table 1 as published. BZBS is a post-marketing drug, and there is an error in the components of BZBS and ratio amounts in application (Li et al., 2021). The corrected Table 1 appears below.

TABLE 1.

The ratio of the plants present in the preparation of BZBS.

Plants	Amount in application (ratio)
Cuscuta chinensis Lam. [Convolvulaceae; Cuscutae semen]	250
Lycium barbarum L. [Solanaceae; Lycii cortex]	138
Schisandra chinensis (Turcz.) Baill. [Schisandraceae; Schisandrae chinensis fructus]	46
Cnidium monnieri (L.) Cusson [Apiaceae; Cnidii fructus]	35
Rosa laevigata Michx. [Rosaceae; Rosae laevigatae fructus]	35
Rubus chingii Hu [Rosaceae; Rubi fructus]	35
Allium tuberosum Rottler ex Spreng. [Amaryllidaceae; Allii tuberosi semen]	35
Toosendan fructus [Meliaceae; Fuctus Toosendan]	23
Epimedium brevicornu Maxim. [ Berberidaceae; Epimedii folium]	70
Morindae officinalis radix [Rubiaceae; Radix Morindae Offcinalis]	35
Cistanche deserticola Ma [Orobanchaceae; Cistanches herba]	35
Rehmannia root [Orobanchaceae; Radix Rehmanniae Recens]	46
Cyathula officinalis K.C.Kuan [Amaranthaceae; Cyathulae radix]	35
Panax ginseng C.A.Mey. [Araliaceae; Ginseng radix et rhizoma]	25
Cervus nippon Temminck [Cervidae; Cervi Cornu Pantotrichum]	16
Hippocampus Kelloggi [Syngnathidae; Hippocampus]	21

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.